Health Care & Life Sciences » Pharmaceuticals » Personalized medicine | Obstacles for developing personalized medicine 2015

Major obstacles for personalized medicine according to pharma companies 2015

Major obstacles for developing personalized medicines according to pharmaceutical companies worldwide as of 2015

The data are based on a survey conducted during the 2nd quarter of 2015. It describes major obstacles for developing personalized medicines according to pharmaceutical companies in Asia, Europe, and in the U.S. Most of respondents stated that the lack of a regulatory guidance would be the major obstacle for developing personalized medicines.

Lack of regulatory guidance	34
Disease/patient stratification	18
Uncertain ROI given small populations and R&D costs	14
Designing clinical trials/recruiting patients	13
Biomarker validation in targeted indications	11
Matching up companion diagnostic	10

Major obstacles for personalized medicine according to pharma companies 2015

StatInvestor